AU:X (High risk)
None
CA:Schedule IVUK:POM(Prescription only)US:Schedule III
[(8R,9S,10R,13S,14S,17S)-10,13-Dimethyl-3-oxo-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl] undec-10-enoate
13103-34-9
11954310
DBSALT001616
10128605
ZS6D2ITA30
ChEMBL2106059
DTXSID00156854
Interactive image
C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2OC(=O)CCCCCCCCC=C)CCC4=CC(=O)C=C[C@]34C
InChI=1S/C30H44O3/c1-4-5-6-7-8-9-10-11-12-28(32)33-27-16-15-25-24-14-13-22-21-23(31)17-19-29(22,2)26(24)18-20-30(25,27)3/h4,17,19,21,24-27H,1,5-16,18,20H2,2-3H3/t24-,25-,26-,27-,29-,30-/m0/s1Key:AHMMSNQYOPMLSX-CNQKSJKFSA-N
Boldenone undecylenate, orboldenone undecenoate, sold under the brand namesEquipoiseandParenabolamong others, is anandrogenandanabolic steroid(AAS) medication which is used inveterinary medicine, mainly inhorses.It was formerly used in humans as well.It is given byinjection into muscle.
Side effectsof boldenone undecylenate includesymptomsofmasculinizationlikeacne,increased hair growth,voice changes, and increasedsexual desire.The drug is asyntheticandrogen and anabolic steroid and hence is anagonistof theandrogen receptor(AR), thebiological targetof androgens liketestosteroneanddihydrotestosterone(DHT).It has stronganaboliceffects and moderateandrogeniceffects, weakestrogeniceffects, and no risk ofliver damage.Boldenone undecylenate is anandrogen esterand a long-lastingprodrugofboldenonein the body.
Boldenone undecylenate was introduced for medical use in the 1960s.In addition to its medical use, boldenone undecylenate is used toimprove physique and performance.The drug is acontrolled substancein the United States and its use is generally illicit.It remains marketed for veterinary use inAustraliaand theUnited States.
